Lower health care costs by increasing competition, supporting Accountable Care Organizations, and getting cheaper generic drugs to market faster.

The plan says she would lower health costs through more competition, ACOs, and faster access to generics.

Hassan committed to several health cost reduction policies.

Innovate NH 2.0: A Granite State Roadmap for Fostering Innovation, Supporting Job-Creating Businesses and Expanding Opportunity
campaign · campaign_site · model gpt-5.5

unverified · Source version 95780 · locator unknown

for any ingredient for which there is an identified quantitative deviation, the amount of such deviation.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Public Law 119-75 enacted generic-application transparency requirements on February 3, 2026. Section 6703 requires FDA to disclose specified formulation differences, addressing a barrier to generic approval. This establishes partial delivery of the broader commitment, without demonstrating resulting consumer savings. The campaign year was not supplied, so timing relative to the promised term is unknown.

partial unknown

Text - H.R.7148 - 119th Congress (2025-2026): Consolidated Appropriations Act, 2026 | Congress.gov | Library of Congress
secondary · model gpt-6.1-sol · confidence 98%

unverified · Source version 95782 · locator unknown

Sponsor: Sen. Hassan, Margaret Wood [D-NH] (Introduced 04/03/2025)

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Congress.gov establishes Hassan's sponsorship of the generic-application transparency legislation. Corresponding requirements subsequently became law through Section 6703 of the 2026 appropriations act; the standalone bill's introduced status should not obscure that enactment.

partial unknown A for effort

S.1302 - 119th Congress (2025-2026): Increasing Transparency in Generic Drug Applications Act | Congress.gov | Library of Congress
secondary · model gpt-6.1-sol · confidence 98%

unverified · Source version 95784 · locator unknown

Provide rural and safety net hospitals with an opportunity to enter a new accountable care model that sets their Medicare spending benchmark

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The joint framework proposes reducing consolidation incentives through site-neutral payments and supporting hospital participation in accountable care models. It documents concrete policy development relevant to competition and ACO support, but is a proposal rather than proof of enactment or realized savings.

unresolved unknown A for effort

Site-Neutral-Policy-Framework-Final.pdf
secondary · model gpt-6.1-sol · confidence 96%

verified · Source version 95786 · locator 2704

CREATES establishes a private right of action that allows developers to sue brand companies that refuse to sell them product samples

Fetched verbatim passage. AI summary (separate from source): FDA confirms that CREATES was enacted in December 2019 and provides an operational pathway for developers to obtain samples needed for generic and biosimilar applications. This establishes an enacted competition measure, supporting partial delivery of the multi-part promise.

partial unknown

Access to Product Samples: The CREATES Act | FDA
secondary · model gpt-6.1-sol · confidence 99%

unverified · Source version 95788 · locator unknown

02/05/2019 - Sen. Hassan, Margaret Wood [D-NH]*

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The official cosponsor record identifies Hassan as an original cosponsor of CREATES. Together with FDA's enactment record, this connects her legislative effort to the completed measure removing barriers to generic competition.

partial unknown A for effort

Cosponsors - S.340 - 116th Congress (2019-2020): A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. | Congress.gov | Library of Congress
secondary · model gpt-6.1-sol · confidence 99%